Previous 10 | Next 10 |
Milestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference Canada NewsWire MONTREAL and CHARLOTTE, N.C., May 27, 2020 MONTREAL and CHARLOTTE, N.C. , May 27, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical compa...
Milestone Pharmaceuticals (NASDAQ: MIST ): Q1 GAAP EPS of -$0.67 beats by $0.07 . More news on: Milestone Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update Canada NewsWire MONTREAL and CHARLOTTE, N.C., May 14, 2020 MONTREAL and CHARLOTTE, N.C. , May 14, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST...
Gainers: Stemline Therapeutics (NASDAQ: STML ) +154% . More news on: Stemline Therapeutics, Inc., MicroVision, Inc., Contango Oil & Gas Company, Stocks on the move, , Read more ...
When it comes to finding the best penny stocks to buy , you’ve got your choice of platform. Some will use mobile applications like Robinhood and WeBull, for instance. Meanwhile, others will opt for more traditional, desk-top based platforms like TD Ameritrade’s ThinkOrSwim or E-Tr...
Gainers: Medigus (NASDAQ: MDGS ) +44% . More news on: Medigus Ltd., Indonesia Energy Corporation Limited, National Holdings Corporation, Stocks on the move, , Read more ...
Astrotech (NASDAQ: ASTC ) +175% on developing screening instrument for COVID-19. More news on: Astrotech Corporation, Happiness Biotech Group Limited, Apollo Commercial Real Estate Finance, Inc., Stocks on the move, , Read more ...
Menlo Therapeutics (NASDAQ: MNLO ) initiated with Overweight rating and $8 (161% upside) price target at Barclays. More news on: Menlo Therapeutics Inc., Molecular Templates, Inc., Passage Bio, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Gainers: ThermoGenesis (NASDAQ: THMO ) +164% . More news on: ThermoGenesis Holdings, Inc., U.S. Gold Corp., Sientra, Inc., Stocks on the move, , Read more ...
Milestone Pharmaceuticals (NASDAQ: MIST ) -74% on failed etripamil study. More news on: Milestone Pharmaceuticals Inc., Invesco Mortgage Capital Inc., Baudax Bio, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Milestone Pharmaceuticals Inc. Company Name:
MIST Stock Symbol:
NASDAQ Market:
Milestone Pharmaceuticals Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will host Part I of its virtual investor educ...
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in the Jefferies Global Healthcare Conference being held in New York City, NY from June 4-6, 2024. ...